...
首页> 外文期刊>Hellenic Journal of Cardiology >Left atrial strain, intervendor variability, and atrial fibrillation recurrence after catheter ablation: A systematic review and meta-analysis
【24h】

Left atrial strain, intervendor variability, and atrial fibrillation recurrence after catheter ablation: A systematic review and meta-analysis

机译:在导管消融后左心房菌株,干预员可变性和心房颤动复发:系统评价和荟萃分析

获取原文
           

摘要

The aim of this systematic review and meta-analysis is to investigate the capacity of preinterventional left atrial strain (LAS) to predict AF recurrence (AFR) after catheter ablation by using all relative published data. Intervendor variability regarding different ultrasound stations and strain analysis software suites was taken into consideration. The research was performed according to PRISMA guidelines. The Cochrane database, MEDLINE, and EMBASE were searched for studies assessing echocardiography LAS prior to catheter ablation of AF cases. The systematic research yielded 10 studies (2 retrospective and 8 prospective, 880 patients in total). LAS differed significantly between the patients with AFR and those with no AF recurrence (nAFR) during the follow-up period (LAS AFR : 17.5?±?8.7% vs. LAS nAFR : 24.1?±?9.5%, p??0.00001). A pooled cutoff value of 21.9% for LAS was extracted for the prediction of ablation success. Regarding intervendor variability, subgroup analyses were able to be performed for studies using GE and TomTec software. The difference in LAS AFR and LAS nAFR remained significant (p??0.00001 and p??0.0001 for TomTec and GE, respectively), while significant intervendor difference in absolute strain values was also detected (p??0.0001 for both AFR and nAFR groups). LAS prior to catheter ablation is consistently lower in patients who experience AF recurrence. Its incorporation in clinical practice would assist physicians detect patients who require closer follow-up. Intervendor variability appears to be considerable and steps must be taken to document it thoroughly and mitigate it if possible.
机译:该系统审查和荟萃分析的目的是研究初步左心房菌株(LAS)通过使用所有相对公开的数据在导管消融后预测AF复发(AFR)的能力。考虑有关不同超声站和应变分析软件套件的干预员变异。该研究是根据Prisma准则进行的。搜索Cochrane数据库,MEDLINE和EMBASE用于在AF病例的导管消融之前评估超声心动图LAS的研究。系统研究产生了10项研究(2个回顾性和8个前景,总共880名患者)。在随访期间,AFR和NA缺血(NAFR)的患者之间的LAS有显着不同(LAS AFR:17.5?±±8.7%与LAS NAFR:24.1?±9.5%,P?<0.00001 )。提取LAS的汇集截止值为21.9%的融合成功预测。关于干预员可变性,能够使用GE和Tomtec软件进行研究的子组分析。 Las AFR和LAS NAFR的差异仍然很大(P?<〜0.00001和P?<〜0.0001,分别用于TOMTEC和GE),同时还检测到绝对应变值中的显着干预率差异(P?<?0.0001两个AFR和nafr组)。导管消融前的LAS在经历AF复发的患者中始终如一。其在临床实践中的融合将帮助医生检测需要更接近随访的患者。干预员可变性似乎是可观的,并且必须采取步骤彻底记录并在可能的情况下减轻它。
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号